NCT03635645Recruiting
Experimental and Clinical Studies of Retinal Stimulation
Source: ClinicalTrials.gov · Last updated 14 Dec 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study will evaluate new methods of retinal stimulation and training with the goal of improving the visual ability of retinal prosthesis participants.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 26 Jul 2018
- Start date
- 30 Oct 2017
- Primary completion date
- 30 Oct 2023
- Lead sponsor
- University of Michigan
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT03635645
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 30 Oct 2017 to the primary completion date, 30 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects participating in another investigatory drug or device study
Other illness
- Any disease or condition that prevents understanding or communication of informed consent, study demands, and testing protocols.
Who the study is looking for
- Must be implanted with an Argus II Retinal Prosthesis system.
- Have 5 or more electrodes that create a perception with stimulation.
- Must be willing and able to comply with the protocol testing requirements.
Age in the registry: 25 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Coordinator of this site? Confirm its status | Ann Arbor | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.